Patient info Open main menu

Alendronic acid 70mg oral solution – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
70 mg (700 microgram/ml)
Contains active substance:

Patient leaflet - Alendronic Acid 70 mg oral solution

1. WHAT ALENDRONIC ACID IS AND WHAT IT IS USED FOR

Alendronic acid belongs to a group of non-hormonal medicines called bisphosphonates. Alendronic acid is used to

  • Prevent the loss of bone (osteoporosis) that occurs in women after they have been through the menopause, and helps to rebuild bone.
  • Reduces the risk of spine and hip fractures.

Your doctor has prescribed Alendronic acid to treat your osteoporosis and to reduce the risk of spine and hip fractures.

What is osteoporosis?

Osteoporosis is a thinning and weakening of the bones. It is common in women after the menopause. At the menopause, the ovaries stop producing the female hormone, oestrogen, which helps to keep a woman’s skeleton healthy. As a result, bone loss occurs and bones become weaker. The earlier a woman reaches the menopause, the greater the risk of osteoporosis.

Early on, osteoporosis usually has no symptoms. If left untreated, however, it can result in broken bones. Although these usually hurt, breaks in the bones of the spine may go unnoticed until they cause height loss. Broken bones can happen during normal, everyday activity, such as lifting or from minor injury that would not generally break normal bone. Broken bones usually occur at the hip, spine or wrist and can lead not only to pain but also to considerable problems like stooped posture (‘dowager’s hump’) and loss of mobility.

How can osteoporosis be treated?

Osteoporosis can be treated and it is never too late to begin treatment. Alendronic acid not only prevents the loss of bone but actually helps to rebuild bone you may have lost and reduces the risk of bones breaking in the spine and hip.

As well as your treatment with Alendronic acid your doctor may suggest you make changes to your lifestyle to help your condition, such as:

Stopping smoking: Smoking appears to increase the rate at which you lose bone and, therefore, may increase your risk of broken bones.

Exercise: Like muscles, bones need exercise to stay strong and healthy. Consult your doctor before you begin any exercise programme.

Eating a balanced diet: Your doctor can advise you about your diet or whether you should take any dietary supplements (especially calcium and Vitamin D).

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ALENDRONIC ACID

Do not take Alendronic acid if:-

  • you are allergic (hypersensitive) to alendronic acid or any ingredients of Alendronic acid listed in section 6.
  • you have certain problems with your gullet (oesophagus - the tube that connects your mouth with your stomach) such as narrowing or difficulty swallowing liquids
  • your doctor has told you that you have low blood calcium
  • if you cannot stand or sit upright for at least 30 minutes

If you think any of these apply to you, do not take the solution. Talk to your doctor first and follow the advice given.

Warnings and precautions

Talk to your doctor or pharmacist before taking Alendronic acid if:

  • you suffer from kidney problems
  • you have any allergies
  • you have any swallowing or digestive problems
  • your doctor has told you that you have Barrett’s oesophagus (a condition associated with changes in the cells that line the lower oesophagus)
  • you have low blood calcium levels
  • you have poor dental health
  • you have a planned dental extraction
  • you have cancer
  • you are undergoing chemotherapy or radiotherapy
  • you are taking corticosteroids (such as prednisone or dexamethasone)
  • you are taking angiogenesis inhibitors (such as bevacizumab, or thalidomide)
  • you don’t receive routine dental care
  • you have gum disease
  • you are or have been a smoker (as this may increase the risk of dental problems)

You may be advised to have a dental check-up before starting treatment with Alendronic acid. Appropriate preventive dental care, as recommended by the dentist, should be followed during treatment. You should contact your doctor or dentist if you experience any problems with your mouth or teeth such as loose teeth, pain or swelling.

Irritation, inflammation or ulceration of the gullet (oesophagus – the tube that connects your mouth with your stomach) often with symptoms of chest pain, heartburn, or difficulty or pain upon swallowing may occur, especially if patients lie down after taking Alendronic acid. These side effects may worsen if patients continue to take Alendronic acid after developing these symptoms.

Children and adolescents

Alendronic acid should not be given to children and adolescents under the age of 18 years due to insufficient data on safety and efficacy.

Other medicines and Alendronic acid

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medications.

It is likely that calcium supplements, antacids, and some oral medicines will interfere with the absorption of Alendronic acid if taken at the same time. Therefore, it is important that you follow the advice given in section 3. ‘HOW TO TAKE ALENDRONIC ACID’.

Certain medicines for rheumatism or long-term pain called NSAIDs (e.g. aspirin or ibuprofen) might cause digestive problems. Therefore, caution should be used when these medicines are taken at the same time as Alendronic acid.

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

Alendronic acid with food and drink and alcohol

It is likely that food and beverages (including mineral water) will make Alendronic acid less effective if taken at the same time. Therefore, it is important that you follow the advice given in section 3. ‘HOW TO TAKE ALENDRONIC ACID’

Pregnancy and breast-feeding

Alendronic acid is only intended for use in postmenopausal women.

You should not take Alendronic acid if you are or think you may be pregnant, or if you are breast-feeding. Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

There have been side effects (including blurred vision, dizziness and severe bone, muscle or joint pain) reported with Alendronic acid that may affect your ability to drive or operate machinery. Individual responses to Alendronic acid may vary (See Section 4 ‘POSSIBLE SIDE EFFECTS’).

Important information about some of the ingredients of Alendronic acid

This medicinal product contains sunset yellow (E110), methyl- and propyl-parahydroxybenzoates (E218, E216) that may cause allergic reactions (possibly delayed). Allergy is more common if you are allergic to aspirin. You should check with your doctor or pharmacist if you are not sure.

This medicinal product contains 0.15 vol % ethanol (alcohol) i.e. up to 115mg per dose, equivalent to 3ml beer, 1.3ml wine per dose. This may be harmful to those suffering from alcoholism and also should be taken into account in high risk groups such as patients with liver disease or epilepsy.

3. HOW TO TAKE ALENDRONIC ACID

Always take Alendronic acid exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

The recommended dosage is one 70mg unit-dose (100ml) once weekly.

Follow these instructions carefully to make sure you will benefit from Alendronic acid.

Choose the day of the week that best fits your schedule. Every week, take Alendronic acid on your chosen day.

It is very important to follow these instructions to help the Alendronic acid reach your stomach quickly and help reduce the chance of irritating your gullet (oesophagus - the tube that connects your mouth with your stomach).

  • After getting up for the day and before taking any food, drink, or other medicine, swallow your Alendronic acid.
  • Drink one entire bottle of solution followed by at least 30ml (one sixth of a glass) of plain water. Additional water (plain) may be taken.
  • Do not take with mineral water (still or sparkling), coffee, tea, juice or milk.
  • Do not lie down – stay fully upright (sitting, standing or walking) – for at least 30 minutes after taking the solution. Do not lie down until after your first food of the day.
  • Do not take Alendronic acid at bedtime or before arising for the day
  • If you develop difficulty or pain upon swallowing, chest pain or new or worsening heartburn, contact your doctor
  • After swallowing your Alendronic acid, wait at least 30 minutes before taking your first food, drink, or other medicine of the day, including antacids, calcium supplements and vitamins. Alendronic acid is effective only if taken when your stomach is empty.

If you take more Alendronic acid than you should

If you take too much solution by mistake, drink a full glass of milk and contact your doctor immediately. Do not make yourself vomit, and do not lie down.

If you forget to take Alendronic acid

If you miss a dose, just take the dose on the morning after you remember. Do not take two doses on the same day. Return to taking one dose once a week, as originally scheduled on your chosen day.

If you stop taking Alendronic acid

It is important that you continue taking Alendronic acid for as long as your doctor prescribes the medicine. Alendronic acid can treat your osteoporosis only if you continue to take the solution.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, Alendronic acid can cause side effects, although not everybody gets them.

See your doctor immediately if you notice any of the following side effects, which may be serious and for which you may need urgent medical treatment:

Common: may affect up to 1 in 10 people

  • heartburn; difficulty swallowing; pain upon swallowing; ulceration of the gullet (oesophagus - the tube that connects your mouth with your stomach) which can cause chest pain, heartburn or difficulty or pain upon swallowing

Rare: may affect up to 1 in 1,000 people

  • allergic reactions such as hives; swelling of the face, lips, tongue and/or throat, possibly causing difficulty breathing or swallowing and severe skin reactions
  • pain in the mouth, and/or jaw, swelling or sores inside the mouth, numbness or a feeling of heaviness in the jaw, or loosening of a tooth. These could be signs of bone damage in the jaw (osteonecrosis) generally associated with delayed healing and infection, often following tooth extraction or if you are receiving treatment for cancer.
  • unusual fracture of the thigh bone particularly in patients on long-term treatment for osteoporosis may occur rarely. Contact your doctor if you experience pain, weakness or discomfort in your thigh, hip or groin as this may be an early indication of a possible fracture of the thigh bone

Other side effects include:

Very common:

  • bone, muscle and/or joint pain which is sometimes severe.

Common: may affect up to 1 in 10 people

  • abdominal pain; uncomfortable feeling in the stomach or belching after eating; indigestion, constipation; full or bloated feeling in the stomach; diarrhoea; flatulence
  • headache, dizziness
  • Joint swelling
  • Itching
  • Alopecia (Hair Loss)
  • Tiredness / weakness,
  • swelling in the hands or legs
  • Whirling or spinning motion associated with dizziness (vertigo)

Uncommon: may affect up to 1 in 100 people

  • nausea; vomiting
  • irritation or inflammation of the gullet (oesophagus – the tube that connects your mouth with your stomach) or stomach
  • black or tar-like stools
  • blurred vision, pain or redness in the eye
  • rash; redness of the skin
  • transient flu-like symptoms, such as aching muscles, generally feeling unwell and sometimes with fever usually at the start of treatment
  • taste disturbance

Rare: may affect up to 1 in 1,000 people

  • symptoms of low blood calcium levels including muscle cramps or spasms and/or tingling sensation in the fingers or around the mouth
  • stomach or peptic ulcers (sometimes severe or with bleeding)
  • narrowing of the gullet (oesophagus – the tube that connects your mouth with your stomach)
  • rash made worse by sunlight
  • unusual fracture of the thigh bone particularly in patients on long-term treatment for osteoporosis may occur rarely. Contact your doctor if you experience pain, weakness or discomfort in your thigh, hip or groin as this may be an early indication of a possible fracture of the thigh bone

Very rare: may affect up to 1 in 10,000 people

  • Talk to your doctor if you have ear pain, discharge from the ear, and/or an ear infection. These could be signs of bone damage in the ear.

Tell your doctor or pharmacist promptly about these or any other unusual symptoms.

It will help if you make a note of what you experienced, when it started and how long it lasted.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. HOW TO STORE ALENDRONIC ACID

Keep out of the sight and reach of children.

Do not store above 25°C.

Do not use Alendronic acid after the expiry date which is stated on the carton and bottle labels after 'Exp'. The expiry date refers to the last day of that month.

If the solution becomes discoloured or shows any signs of deterioration, seek the advice of your pharmacist.

Remember if your doctor tells you to stop taking this medicine, return any unused medicine to your pharmacist for safe disposal. Only keep this medicine if your doctor tells you to.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Alendronic acid contains

The active ingredient is alendronic acid (as alendronate sodium trihydrate).

Each 100ml single-dose contains 70mg alendronic acid (as 91.4mg alendronate sodium trihydrate).

The other ingredients are xanthan gum (E415), sodium cyclamate (E952), sucralose (E955), sunset yellow FCF (E110), methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), orange flavour containing ethanol and butylated hydroxyanisole (E320) and purified water.

What Alendronic acid looks like and contents of the pack

Alendronic acid is an orange coloured solution.

It is available in clear polyethylene terephthalate (PET) bottles with a tamper-evident closure in pack size of 4 bottles.

Each bottle contains 100ml of solution and is for single use only.

Manufactured by: PINEWOOD LABORATORIES LTD, Ballymacarbry, Clonmel, County Tipperary, Ireland.

Procured from within the EU and repackaged by the Product Licence holder: B&S Healthcare, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, UK.

Alendronic acid 70mg oral solution; PL 18799/4192

Leaflet date: 13.06.2025

Blind or partially sighted?

Is this leaflet hard to see or read?

Call 0208 515 3763 to obtain the leaflet in a format suitable for you.

POM

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 18799/4192

Last revision stated in the text: 13 June 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Alendronic Acid 70 mg oral solution

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Alendronic acid
Strength 70 mg (700 microgram/ml)
Pharmaceutical form Oral solution
How is it taken Oral
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. M Musculo-skeletal system drugs
    1. M05 Drugs for treatment of bone diseases
      1. M05B Drugs affecting bone structure and mineralization
        1. M05BA Bisphosphonate drugs affecting bone structure and mineralization
          1. M05BA04 alendronic acid
Marketing authorisation PLPI 18799/4192
Codes BNF 06060200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.